Malaria is a disease of public health importance in many parts of the world. Currently, there
is no effective way to eradicate malaria, so developing safe, efficient, and cost‐effective …

Malaria is a parasitic disease of major global health significance that causes an estimated
2.7 million deaths each year. In this review we describe the burden of malaria and discuss …

The development and implementation of a malaria vaccine would constitute a major
breakthrough for global health. Recently, numerous new candidates have entered clinical …

Although the malaria parasite was discovered more than 120 years ago, it is only during the
past 20 years, following the cloning of malaria genes, that we have been able to think …

Malaria vaccine discovery and development follow two principal strategies. Most subunit
vaccines are designed to mimic naturally acquired immunity that develops over years upon …

Despite global efforts to control malaria, the illness remains a significant public health threat.
Currently, there is no licensed vaccine against malaria, but an efficacious vaccine would …

Vaccines are the most cost-effective tools to control infectious diseases, yet the complexity of
malaria has frustrated all attempts to develop an effective product. This review concentrates …

The development of an effective malaria vaccine has taken many decades, but there is now
a good chance that the first malaria vaccine will be licensed within the next few years …

Plasmodium falciparum malaria is a major global health problem, responsible for up to 1
million deaths each year. Major efforts have been made to develop an effective vaccine …

The complex life cycle of the malaria parasite Plasmodium falciparum provides many
options for vaccine design. Several new types of vaccine are now being evaluated in clinical …